Symbols / MBX $32.99 +2.17% MBX Biosciences, Inc.

Healthcare • Biotechnology • United States • NMS
MBX Chart
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 1.57B
Enterprise Value 1.19B Income -86.97M Sales
Book/sh 8.22 Cash/sh 7.87 Dividend Yield
Payout 0.00% Employees 63 IPO
P/E Forward P/E -8.12 PEG
P/S P/B 4.01 P/C
EV/EBITDA -12.21 EV/Sales Quick Ratio 24.25
Current Ratio 24.62 Debt/Eq 0.16 LT Debt/Eq
EPS (ttm) -2.38 EPS next Y -4.06 EPS Growth
Revenue Growth Earnings 2026-05-11 ROA -18.75%
ROE -27.76% ROIC Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 47.51M
Shs Float 29.03M Short Float 9.72% Short Ratio 5.00
Short Interest 52W High 44.89 52W Low 4.81
Beta Avg Volume 632.33K Volume 601.68K
Target Price $62.55 Recom Strong_buy Prev Close $32.29
Price $32.99 Change 2.17%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-19.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest MBX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 HAWRYLUK P KENT Chief Executive Officer 18,500 $28.41 $525,663
2026-02-26 HAWRYLUK P KENT Chief Executive Officer 28,768 $16.00 $460,288
2026-02-02 HAWRYLUK P KENT Chief Executive Officer 35,250 $0.00 $0
2026-02-02 BARTRAM RICHARD B Chief Financial Officer 15,000 $0.00 $0
2026-02-02 AZOULAY SALOMON M.D. Officer 15,000 $0.00 $0
2025-10-24 HAWRYLUK P KENT Chief Executive Officer 182,859 $3.25 $594,292
2025-10-20 HAWRYLUK P KENT Chief Executive Officer 20,000 $13.64 $272,790
2025-10-17 HOERTER STEVEN L Director 20,000 $13.25 $264,984
2025-09-26 HERON PATRICK J Director and Beneficial Owner of more than 10% of a Class of Security 666,666 $18.00 $11,999,988
2025-04-08 PESCOVITZ ORA H Director 7,693 $5.89 $45,312
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category